Harvard Bioscience Inc 's ability to collect accounts receivable sequentially worsen to 6.16, pointing to a challenging and on top of that deteriorating business climate for the Laboratory Analytical Instruments industry. Average collection period, for Harvard Bioscience Inc 's accounts receivable remained unchanged at 59 days, in the Jun 30 2026 quarter.

If we take a look into Healthcare sector 281 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Jun 30 2026 from 650 to 2184.

What is Receivable Turnover Ratio?
What is Harvard Bioscience Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

HBIO Receivables Turnover Ratio	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Receivable Change	21.47 %	8.11 %	7.92 %	-5.63 %	-4.4 %
Y / Y Revenue Change	16.35 %	-4.44 %	-3.23 %	-8.01 %	-12.08 %
Receivable Turnover Ratio (TTM)	6.16	6.22	6.42	6.62	6.66
HBIO's Total Ranking	# 2184	# 650	# 1886	# 1930	# 927
Accounts Receivable average collection period days	59	59	57	55	55
Seq. Receivable Change	-0.49 %	-9.17 %	32.49 %	1.44 %	-11.44 %
Seq. Revenue Change	12.27 %	-19.58 %	25.73 %	2.5 %	-7.79 %

Receivable Turnover Company Ranking
Within:	No.
Laboratory Analytical Instruments Industry	# 9
Healthcare Sector	# 282
Overall Market	# 2184

Receivable Turnover Ratio Statistics
High	Average	Low
7.75	6.67	5.94
(Dec 31 2012)		(Mar 31 2018)

HBIO Company Profile • Back to HBIO Efficiency Comparisons • Compare HBIO Receivables Turnover Ratio to its Competitors

Financial Statements
Harvard Bioscience Inc 's Accounts Receivable	$ 15 Millions	Visit HBIO's Balance sheet
Harvard Bioscience Inc 's Sales TTM	$ 88 Millions	Visit HBIO's Income Statement
Sources of HBIO's Revenues		Visit HBIO's Sales by Geography

Other Accounts Receivable Turnover Ratios
Laboratory Analytical Instruments Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
HBIO's Receivable Turnover Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
HBIO's Growth Rates	HBIO's Roa	HBIO's Inventory Turnover Ratio	HBIO's Dividend Comparisons
HBIO's Profitability Ratios	HBIO's Roi	HBIO's Asset Turnover Ratio	HBIO's Dividend Growth
HBIO's Valuation Ratios	HBIO's Roe	HBIO's Financial Strength Ratios	HBIO's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Jun 30 2026	Receivable at quarter ending Jun 30 2026
Anika Therapeutics Inc	16.70	$ 121.370 Millions	$ 7.266 Millions
Lifemd Inc	16.48	$ 163.363 Millions	$ 9.915 Millions
Longeveron Inc	16.43	$ 1.187 Millions	$ 0.072 Millions
Bioage Labs Inc	15.82	$ 10.355 Millions	$ 0.655 Millions
Vaxart Inc	15.09	$ 243.064 Millions	$ 16.108 Millions
Medicinova Inc	15.02	$ 0.920 Millions	$ 0.061 Millions
Voyager Therapeutics Inc	14.71	$ 34.459 Millions	$ 2.343 Millions
Halozyme Therapeutics Inc	14.68	$ 1,663.738 Millions	$ 113.332 Millions
Nexgel Inc	14.52	$ 11.810 Millions	$ 0.813 Millions
Skinhealth Systems Inc	14.42	$ 289.224 Millions	$ 20.051 Millions
Lftd Partners Inc	14.13	$ 35.335 Millions	$ 2.500 Millions
Talkspace Inc	14.09	$ 246.631 Millions	$ 17.506 Millions
Lifestance Health Group Inc	14.07	$ 1,584.834 Millions	$ 112.665 Millions
10x Genomics Inc	13.90	$ 616.566 Millions	$ 44.342 Millions
Amneal Pharmaceuticals Inc	13.90	$ 3,117.474 Millions	$ 224.342 Millions
Ataibeckley Inc	13.83	$ 4.473 Millions	$ 0.324 Millions
Corcept Therapeutics Inc	13.54	$ 830.813 Millions	$ 61.352 Millions
Rosecliff Acquisition Corp I	13.43	$ 16.467 Millions	$ 1.226 Millions
Precipio inc	13.25	$ 27.198 Millions	$ 2.052 Millions
Chemed Corporation	12.94	$ 2,595.001 Millions	$ 200.565 Millions
Qhslab Inc	12.77	$ 3.017 Millions	$ 0.236 Millions
Nrc Health	12.72	$ 139.996 Millions	$ 11.004 Millions
Mannkind Corporation	12.39	$ 393.630 Millions	$ 31.773 Millions
Petvivo Holdings Inc	12.34	$ 1.182 Millions	$ 0.096 Millions
Siga Technologies Inc	12.32	$ 53.659 Millions	$ 4.356 Millions
Alpha Pro Tech Ltd	12.25	$ 62.204 Millions	$ 5.077 Millions
Vivos Therapeutics Inc	12.21	$ 21.135 Millions	$ 1.731 Millions
Milestone Scientific Inc	11.98	$ 8.855 Millions	$ 0.739 Millions
Teladoc Health Inc	11.88	$ 2,489.480 Millions	$ 209.556 Millions
Premier Air Charter Holdings Inc	11.72	$ 31.562 Millions	$ 2.692 Millions

Date modified: 2026-09-08T18:02:22+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.